The US pharmaceutical company Pfizer almost doubled its sales last year thanks to the Covid 19 vaccine marketed jointly with Biontech. Pfizer had sales of around $81.3 billion in 2021, after $41.7 billion in the previous year. Without the contributions of the vaccine Comirnaty and the anti-corona pill Paxlovid, sales would have increased by six percent to $ 44.4 billion, the group said. Net income jumped to $21.9 billion from $9.2 billion a year ago. “The company is in better shape than it has ever been in my almost 15 years here,” said CFO Frank D’Amelio. If Pfizer meets its guidance for the current year, it would be the highest annual sales and adjusted earnings per share in the history of the pharmaceutical company, which was founded in 1849 by German emigrants Karl Pfizer and Karl Erhart. In 2020, Pfizer made the most sales with cancer drugs, this division has now been surpassed by the vaccine business by a huge margin.
Pharma – Vaccine business boosts Pfizer – Economy
